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Learning Objectives
• Understand the process of cohort selection using large, retrospective databases.
• Learn about additional speciﬁc skills in cohort building including data visual-
ization and natural language processing (NLP).
10.1 Introduction
A critical ﬁrst step in any observational study is the selection of an appropriate
patient cohort for analysis. The importance of investing considerable time and effort
into selection of the study population cannot be overstated. Failure to identify areas
of potential bias, confounding, and missing data up-front can lead to considerable
downstream inefﬁciencies. Further, care must be given to selecting a population of
patients tailored to the research question of interest in order to properly leverage the
tremendous amount of data captured by Electronic Health Records (EHRs).
In the following chapter we will focus on selection of the study cohort.
Speciﬁcally, we will review the basics of observational study design with a focus on
types of data often encountered in EHRs. Commonly used instrumental variables
will be highlighted—they are variables used to control for confounding and mea-
surement error in observational studies. Further, we will discuss how to utilize a
combination of data-driven techniques and clinical reasoning in cohort selection.
The chapter will conclude with a continuation of the worked example started in part
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one of this section where we will discuss how the cohort of patients was selected for
the study of arterial line placement in the intensive care unit [1].
10.2 PART 1—Theoretical Concepts
10.2.1 Exposure and Outcome of Interest
These notions are discussed in detail in Chap. 9—“Formulating the Research
Question”. Data mining in biomedical research utilizes a retrospective approach
wherein the exposure and outcome of interest occur prior to patient selection. It is
critically important to tailor the exposure of interest sought to the clinical question at
hand. Selecting an overly broad exposure may allow for a large patient cohort, but at
the expense of result accuracy. Similarly, being too speciﬁc in the choice of exposure
may allow for accuracy but at the expense of sample size and generalizability.
The selection of an exposure of interest is the ﬁrst step in determining the patient
cohort. In general, the exposure of interest can be thought of as patient-centric,
episode-centric, or encounter centric. This terminology was developed by the data
warehousing ﬁrm Health Catalyst for their Cohort Builder tool and provides a
reasonable framework for identifying an exposure of interest. Patient-centric
exposures focus on traits intrinsic to a group of patients. These can include
demographic traits (e.g. gender) or medical comorbidities (e.g. diabetes). In con-
trast, episode-centric exposures are transient conditions requiring a discrete treat-
ment course (e.g. sepsis). Encounter-centric exposures refer to a single intervention
(e.g. arterial line placement) [2]. Although encounter-speciﬁc exposures tend to be
simpler to isolate, the choice of exposure should be determined by the speciﬁc
hypothesis under investigation.
The outcome of interest should be identiﬁed a priori. The outcome should relate
naturally to the exposure of interest and be as speciﬁc as possible to answer the
clinical question at hand. Care must be taken to avoid identifying spurious corre-
lations that have no pathophysiologic underpinnings (see for instance the examples
of spurious correlations shown on http://tylervigen.com). The relationship sought
must be grounded in biologic plausibility. Broad outcome measures, such as mor-
tality and length-of-stay, may be superﬁcially attractive but ultimately confounded
by too many variables. Surrogate outcome measures (e.g. change in blood pressure,
duration of mechanical ventilation) can be particularly helpful as they relate more
closely to the exposure of interest and are less obscured by confounding.
As EHRs are not frequently oriented towards data mining and analysis, identi-
fying an exposure of interest can be challenging. Structured numerical data, such as
laboratory results and vital signs, are easily searchable with standard querying
techniques. Leveraging unstructured data such as narrative notes and radiology
reports can be more difﬁcult and often requires the use of natural language pro-
cessing (NLP) tools. In order to select a speciﬁc patient phenotype from a large,
heterogeneous group of patients, it can be helpful to leverage both structured and
unstructured data forms.
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Once an exposure of interest is selected, the investigator must consider how to
utilize one or a combination of these data types to isolate the desired study cohort
for analysis. This can be done using a combination of data driven techniques and
clinical reasoning as will be reviewed later in the chapter.
10.2.2 Comparison Group
In addition to isolating patients mapping to the exposure of interest, the investigator
must also identify a comparison group. Ideally, this group should be comprised of
patients phenotypically similar to those in the study cohort but who lack the
exposure of interest. The selected comparison cohort should be at equal risk of
developing the study outcome. In observational research, this can be accom-
plished notably via propensity score development (Chap. 23—“Propensity Score
Analysis”). In general, the comparison group ought to be as large as or larger than
the study cohort to maximize the power of the study. It is possible to select too
many features on which to ‘match’ the comparison and study cohorts thereby
reducing the number of patients available for the comparison cohort. Care must be
taken to prevent over-matching.
In select cases, investigators can take advantage of natural experiments in which
circumstances external to the EHR readily establish a study cohort and a compar-
ison group. These so called ‘instrumental variables’ can include practice variations
between care units, hospitals, and even geographic regions. Temporal relationships
(i.e. before-and-after) relating to quality improvement initiatives or expert guideline
releases can also be leveraged as instrumental variables. Investigators should be on
the lookout for these highly useful tools.
10.2.3 Building the Study Cohort
Isolating speciﬁc patient phenotypes for inclusion in the study and comparison
cohorts requires a combination of clinical reasoning and data-driven techniques.
A close working relationship between clinicians and data scientists is an essential
component of cohort selection using EHR data.
The clinician is on the frontline of medical care and has direct exposure to
complex clinical scenarios that exist outside the realm of the available
evidence-base. According to a 2011 Institute of Medicine Committee Report, only
10–20 % of clinical decisions are evidence based [3]. Nearly 50 % of clinical
practice guidelines rely on expert opinion rather than experimental data [4]. In this
‘data desert’ it is the role of the clinician to identify novel research questions
important for direct clinical care [5]. These questions lend themselves naturally to
the isolation of an exposure of interest.
10.2 PART 1—Theoretical Concepts 95
Once a clinical question and exposure of interest have been identiﬁed, the
clinician and data scientist will need to set about isolating a patient cohort.
Phenotype querying of structured and unstructured data can be complex and
requires frequent tuning of the search criteria. Often multiple, complementary
queries are required in order to isolate the speciﬁc group of interest. In addition, the
research team must consider patient ‘uniqueness’ in that some patients have mul-
tiple ICU admissions both during a single hospitalization and over repeat hospital
visits. If the same patient is included more than once in a study cohort, the
assumption of independent measures is lost.
Researchers must pay attention to the necessity to exclude some patients on the
grounds of their background medical history or pathological status, such as preg-
nancy for example. Failing to do so could introduce confounders and corrupt the
causal relationship of interest.
In one example from a published MIMIC-II study, the investigators attempted to
determine whether proton pump inhibitor (PPI) use was associated with hypo-
magnesaemia in critically-ill patients in the ICU [6]. The exposure of interest in this
study was ‘PPI use.’ A comparison group of patients who were exposed to an
alternative acid-reducing agent (histamine-2 receptor antagonists) and a comparison
group not receiving any acid reducing medications were identiﬁed. The outcome of
interest was a low magnesium level. In order to isolate the study cohort in this case,
queries had to be developed to identify:
1. First ICU admission for each patient
2. PPI use as identiﬁed through NLP analysis of the ‘Medication’ section of the
admission History and Physical
3. Conditions likely to influence PPI use and/or magnesium levels (e.g. diarrheal
illness, end-stage renal disease)
4. Patients who were transferred from other hospitals as medications received at
other hospitals could not be accounted for (patients excluded)
5. Patients who did not have a magnesium level within 36-h of ICU admission
(patients excluded)
6. Patients missing comorbidity data (patients excluded)
7. Potential confounders including diuretic use
The SQL queries corresponding to this example are provided under the name
“SQL_cohort_selection”.
Maximizing the efﬁciency of data querying from EHRs is an area of active
research and development. As an example, the Informatics for Integrating Biology
and the Bedside (i2b2) network is an NIH funded program based at Partner’s Health
Center (Boston, MA) that is developing a framework for simplifying data querying
and extraction from EHRs. Software tools developed by i2b2 are free to download
and promise to simplify the isolation of a clinical phenotype from raw EHR data
https://www.i2b2.org/about/index.html. This and similar projects should help
simplify the large number of queries necessary to develop a study cohort [7].
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10.2.4 Hidden Exposures
Not all exposures of interest can be identiﬁed directly from data contained within
EHRs. In these circumstances, investigators need to be creative in identifying
recorded data points that track closely with the exposure of interest. Clinical rea-
soning in these circumstances is important.
For instance, a research team using the MIMIC II database selected ‘atrial ﬁb-
rillation with rapid ventricular response receiving a rate control agent’ as the
exposure of interest. Atrial ﬁbrillation is a common tachyarrhythmia in critically-ill
populations that has been associated with worse clinical outcomes. Atrial ﬁbrilla-
tion with rapid ventricular response is often treated with one of three rate control
agents: metoprolol, diltiazem, or amiodarone. Unfortunately, ‘atrial ﬁbrillation with
rapid ventricular response’ is not a structured variable in the EHR system connected
to the MIMIC II database. Performing an NLP search for the term ‘atrial ﬁbrillation
with rapid ventricular response’ in provider notes and discharge summaries is
feasible however would not provide the temporal resolution needed with respect to
drug administration.
To overcome this obstacle, investigators generated an algorithm to indirectly
identify the ‘hidden’ exposure. A query was developed to isolate the ﬁrst dose of an
intravenous rate control agent (metoprolol, diltiazem, or amiodarone) received by a
unique patient in the ICU. Next, it was determined whether the heart rate of the
patient within one-hour of recorded drug administration was >110 beats per minute.
Finally, an NLP algorithm was used to search the clinical chart for mention of atrial
ﬁbrillation. Those patients meeting all three conditions were included in the ﬁnal
study cohort. Examples of the Matlab code used to identify the cohort of interest is
provided (function “Aﬁb”), as well as Perl code for NLP (function “NLP”).
10.2.5 Data Visualization
Graphic representation of alphanumeric EHR data can be particularly helpful in
establishing the study cohort. Data visualization makes EHR data more accessible
and allows for the rapid identiﬁcation of trends otherwise difﬁcult to identify. It also
promotes more effective communication both amongst research team members and
between the research team and a general audience not accustomed to ‘Big Data’
investigation. These principles are discussed more extensively in Chap. 15 of this
textbook “Exploratory Data Analysis”.
In the above mentioned project exploring the use of rate control agents for atrial
ﬁbrillation with rapid ventricular response, one outcome of interest was time until
control of the rapid ventricular rate. Unfortunately, the existing literature does not
provide speciﬁc guidance in this area. Using data visualization, a group consensus
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was reached that rate control would be deﬁned as a heart <110 for at least 90 % of
the time over a 4-h period. Although some aspects of this deﬁnition are arbitrary,
data visualization allowed for all team members to come to an agreement on what
deﬁnition was the most statistically and clinically defensible.
10.2.6 Study Cohort Fidelity
Query algorithms are generally unable to boast 100 % accuracy for identifying the
sought patient phenotype. False positives and false negatives are expected. In order
to guarantee the ﬁdelity of the study cohort, manually reviewing a random subset of
selected patients can be helpful. Based on the size of the study cohort, 5–10 % of
clinical charts should be reviewed to ensure the presence or absence of the exposure
of interest. This task should be accomplished by a clinician. If resources permit, two
clinician reviewers can be tasked with this role and their independent results
compared using a Kappa statistic.
Ultimately, the investigators can use the ‘gold standard’ of manual review to
establish a Receiver Operating Characteristic (ROC). An area-under the ROC curve
of >0.80 indicates ‘good’ accuracy of the algorithm and should be used as an
absolute minimum of algorithm ﬁdelity. If the area under the ROC curve is <0.80, a
combination of data visualization techniques and clinical reasoning should be used
to better tune the query algorithm to the exposure of interest.
10.3 PART 2—Case Study: Cohort Selection
In the case study presented, the authors analyzed the effect of indwelling arterial
catheters (IACs) in hemodynamically stable patients with respiratory failure using
multivariate data. They identiﬁed the encounter-centric ‘arterial catheter placement’
as their exposure of interest. IACs are used extensively in the intensive care unit for
beat-to-beat measuring of blood pressure and are thought to be more accurate and
reliable than standard, non-invasive blood pressure monitoring. They also have the
added beneﬁt of allowing for simpler arterial blood gas collection which can reduce
the need for repeated venous punctures. Given their invasive nature, however, IACs
carry risks of bloodstream infection and vascular injury. The primary outcome of
interest selected was 28-day mortality with secondary outcomes that included ICU
and hospital length-of-stay, duration of mechanical ventilation, and mean number
of blood gas measurements made.
The authors elected to focus their study on patients requiring mechanical ven-
tilation that did not require vasopressor and were not admitted for sepsis. In patients
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requiring mechanical ventilation, the dual role of IACs to allow for beat-to-beat
blood pressure monitoring and to simplify arterial blood gas collection is thought to
be particularly important. Patients with vasopressor requirements and/or sepsis were
excluded as invasive arterial catheters are needed in this population to assist with
the rapid titration of vasoactive agents. In addition, it would be difﬁcult to identify
enough patients requiring vasopressors or admitted for sepsis, who did not receive
an IAC.
The authors began their cohort selection with all 24,581 patients included in the
MIMIC II database. For patients with multiple ICU admissions, only the ﬁrst ICU
admission was used to ensure independence of measurements. The function
“cohort1” contains the SQL query corresponding to this step. Next, the patients
who required mechanical ventilation within the ﬁrst 24-h of their ICU admission
and received mechanical ventilation for at least 24-h stay were isolated (function
“cohort2”). After identifying a cohort of patients requiring mechanical ventilation,
the authors queried for placement of an IAC sited after initiation of mechanical
ventilation (function “cohort3”). As a majority of patients in the cardiac surgery
recovery unit had an IAC placed prior to ICU admission, all patients from the
cardiac surgical ICU were excluded from the analysis (function “cohort4”). In order
to exclude patients admitted to the ICU with sepsis, the authors utilized the Angus
criteria (function “cohort5”). Finally, patients requiring vasopressors during their
ICU admission were excluded (function “cohort6”).
The comparison group of patients who received mechanical ventilation for at
least 24-h within the ﬁrst 24-h of their ICU admission but did not have an IAC
placed was identiﬁed. Ultimately, there were 984 patients in the group who received
an IAC and 792 patients who did not. These groups were compared using
propensity matching techniques described in the Chap. 23—“Propensity Score
Analysis”.
Ultimately, this cohort consists of unique identiﬁers of patients meeting the
inclusion criteria. Other researchers may be interested in accessing this particular
cohort in order to replicate the study results or address a different research ques-
tions. The MIMIC website will in the future provide the possibility for investigators
to share cohorts of patients, thus allowing research teams to interact and build upon
other’s work.
Take Home Messages
• Take time to characterize the exposure and outcomes of interest pre-hoc
• Utilize both structured and unstructured data to isolate your exposure and out-
come of interest. NLP can be particularly helpful in analyzing unstructured data
• Data visualization can be very helpful in facilitating communication amongst
team members
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